These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3699081)

  • 1. Bone marrow toxicity of cyclophosphazenes is related to their structure and the treatment schedule.
    Mulder NH; de Vries EG; Timmer-Bosscha H; van de Grampel JC
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):195-8. PubMed ID: 3699081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of trans-N3P3Az2(NHMe)4 (AZP) in non-small cell lung cancer.
    Postmus PE; Mulder NH; Grampel JC; Meyers WH; Berendsen HH
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1207-8. PubMed ID: 2820748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of aziridinylbenzoquinone administered Iv to beagle dogs.
    Hacker MP; Hong CB; McKee MJ; Unwin SE; Urbanek MA
    Cancer Treat Rep; 1982 Oct; 66(10):1845-51. PubMed ID: 7127322
    [No Abstract]   [Full Text] [Related]  

  • 4. Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line.
    Zijlstra JG; de Jong S; van de Grampel JC; de Vries EG; Mulder NH
    Cancer Res; 1986 Jun; 46(6):2726-9. PubMed ID: 3008999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4.
    Mulder NH; Meijers WH; van der Meulen JD; Sleijfer DT; Uges DR; de Vries EG; Postmus PE; van de Grampel JC; Willemse PH
    Cancer Treat Rep; 1987 Feb; 71(2):155-9. PubMed ID: 3026625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes.
    van der Huizen AA; Wilting T; van de Grampel JC; Lelieveld P; van der Meer-Kalverkamp A; Lamberts HB; Mulder NH
    J Med Chem; 1986 Aug; 29(8):1341-5. PubMed ID: 3735303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytostatic activity in vitro of some new cyclophosphazene oligomers.
    Duś D; Brandt K; Wojdat E; Gebarowska E; Jedliński Z; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):539-46. PubMed ID: 2487365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I evaluation of SOAz (1,3,3,5,5 pentakis(aziridino)-1 lambda 6, 2,4,6,3 lambda 5, 5 lambda 5 thiatriaza-diphosphorine-1-oxide) in a weekly schedule.
    Rodenhuis S; Mulder NH; Sleijfer DT; Schraffordt Koops H; Van de Grampel JC
    Eur J Cancer Clin Oncol; 1984 May; 20(5):645-9. PubMed ID: 6539701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming reduces the bone marrow toxicity of carboplatin.
    Gore ME; Hills CA; Siddik ZH; Sloane JP; Winkley AR; Smith IE; Millar JL
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):75-80. PubMed ID: 3297714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical trial of (NPAz2)2NSOAz: 'SOAz'.
    Rodenhuis S; Mulder NH; Sleijfer DT; Koops HS; van de Grampel JC
    Cancer Chemother Pharmacol; 1983; 10(3):178-81. PubMed ID: 6861263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of dominant lethals in mice by fotrin].
    Revazova IuA; Radchenko LU
    Genetika; 1976; 12(2):165-7. PubMed ID: 1269926
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical evaluation of hematopoietic toxicity of antileukemic agent, 5-aza-2'-deoxycytidine.
    Momparler RL; Gonzales FA; Momparler LF; Ma A
    Toxicology; 1989 Aug; 57(3):329-36. PubMed ID: 2474206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(1-Aziridinyl)ethanol.
    IARC Monogr Eval Carcinog Risk Chem Man; 1975; 9():47-50. PubMed ID: 791840
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quantitative aspects of the relationship of the antitumor activity and toxicity of diaziridinyl-sym. triazines to their physicochemical properties].
    Ivin BA; Filov VA; Kraĭz BO; Belogorodskiĭ VV; Maliugina LL
    Vopr Onkol; 1979; 25(7):71-5. PubMed ID: 483685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of the toxicity and antitumor activity of halide derivatives of ethyleneimine].
    Demirchoglian IG; Papoian SA; Babasian OV; Galstian DA; Oganesian MS
    Zh Eksp Klin Med; 1976; 16(5):33-8. PubMed ID: 1023706
    [No Abstract]   [Full Text] [Related]  

  • 16. Bis(1-aziridinyl)morpholinophosphine sulphide.
    IARC Monogr Eval Carcinog Risk Chem Man; 1975; 9():55-60. PubMed ID: 825437
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
    Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
    J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematological toxicity of repeated injections of (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea.
    Rebischung JL; Gougeon MD; Mori KJ; Lemaigre G; Mathé G; Jasmin C
    Cancer Res; 1984 Feb; 44(2):503-6. PubMed ID: 6692356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytostatic activity of inorganic heterocycles in an in vitro screening system.
    Lamberts HB; van der Meer-Kalverkamp A; van de Grampel JC; van der Huizen AA; Jekel AP; Mulder NH
    Oncology; 1983; 40(4):301-4. PubMed ID: 6866426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.